Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 11/01/20111 min de lecture
Trials to Verify and Describe Clinical Benefit of Midodrine Hydrochloride; Establishment of Public Docket
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing the opening of a public docket to provide a forum to facilitate communication regarding the conduct of clinical trials needed to verify and describe the clinical benefit of midodrine hydrochloride (HCl) when used to treat symptomatic orthostatic hypotension.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →